image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Crest Nicholson

March 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRST
  • Price:
  • 310p
The shares soared to a new high of 341p after housebuilder Crest Nicholson announced pretax profit slightly ahead of forecast at £45.9m (FY: ’19: £121.1m) for the year ended 31st October. Net cash of £142m was also ahead of guidance of £135m. Given the pandemic, home completions of 2,247, a reduction of only 23% on FY’19, was a robust performance and limited the sales decline to 37.6% to £678m. Cost savings of £30m have come from its land portfolio while a further £40m gross margin improvements have been identified through better design  of existing and future development schemes. Forward sales as at 15 January were 2,435 units representing £ ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X